Subscribe to NRx Newsletter

The Big Biz Show interviews Jonathan C. Javitt, M.D., M.P.H./Chief Scientist, Director, and Founder, NRx Pharmaceuticals

The Big Biz Show interviews Jonathan C. Javitt, M.D., M.P.H./Chief Scientist, Director, and Founder, NRx Pharmaceuticals, discussing suicidal ideation, NRx-100, IV Ketamine, and the promising findings in Phase 2b/3 clinical trial of NRX-101 vs. Lurasidone for treatment of Suicidal Bipolar Depression.